RxDoctor Payments Data

Crystal Stewart, MD

Family Medicine · Amarillo, TXNPI 1255838785

Payments from drug & device makers

$436in general payments, 2019–2025

Across 19 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$74
  • GSK$70
  • AstraZeneca$51
  • Quest Medical Inc.$43
  • Pfizer$34
  • Medtronic$34
  • plus $130 from 6 others

What the payments were for

  • Food & beverage$436100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$436 in reported general payments places this provider in the 45th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$65,431
Medicare patients
127
Services billed
1,197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$91,886
Trelegy ElliptaFluticasone/Umeclidin/Vilanter98$68,155
JardianceEmpagliflozin38$42,438
MounjaroTirzepatide19$19,880
EliquisApixaban16$13,379
TrulicityDulaglutide11$10,760
TradjentaLinagliptin19$9,945
Spiriva RespimatTiotropium Bromide16$9,714
EntrestoSacubitril/Valsartan13$8,619
Tresiba Flextouch U-100Insulin Degludec13$8,263
Breo ElliptaFluticasone/Vilanterol17$6,590
VascepaIcosapent Ethyl12$5,088
Albuterol Sulfate HfaAlbuterol Sulfate99$2,415
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,394
Atorvastatin Calcium174$1,545

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$70$74,745115 claims
PfizerEliquis$34$13,37916 claims
AbbVieSynthroid$29$44413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Amarillo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →